Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Aneuploidy produces myriad consequences in health and disease, yet models of the deleterious effects of chromosome amplification are still widely debated. To distinguish the molecular determinants of aneuploidy stress, we measured the effects of duplicating individual genes in cells with different chromosome duplications, in wild-type cells (SSD1+) and cells sensitized to aneuploidy by deletion of RNA-binding protein Ssd1 (ssd1Δ). We identified gene duplications that are nearly neutral in wild-type euploid cells but significantly deleterious in euploids lacking SSD1 or in SSD1+ aneuploid cells with different chromosome duplications. Several of the most deleterious genes are linked to translation. In contrast, duplication of other genes benefits multiple ssd1Δ aneuploids over controls, and this group is enriched for translational effectors. Furthermore, both wild-type and especially ssd1Δ aneuploids with different chromosome amplifications show increased sensitivity to translational inhibitor nourseothricin. We used comparative modeling of aneuploid growth defects, based on the cumulative fitness costs measured for single-gene duplication. Our results present a model in which the deleterious effects of aneuploidy emerge from an interaction between the cumulative burden of many amplified genes on a chromosome and a subset of duplicated genes that become toxic in that context. These findings provide a perspective on the dual impact of individual genes and overall genomic burden, offering new avenues for understanding aneuploidy and its cellular consequences.

Free full text 


Logo of plosgenLink to Publisher's site
PLoS Genet. 2024 Oct; 20(10): e1011454.
Published online 2024 Oct 25. https://doi.org/10.1371/journal.pgen.1011454
PMCID: PMC11540229
PMID: 39453980

The response to single-gene duplication implicates translation as a key vulnerability in aneuploid yeast

H. Auguste Dutcher, Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing, 1 , 2 James Hose, Investigation, Methodology, Supervision, 1 Hollis Howe, Investigation, Validation, 1 , ¤ Julie Rojas, Investigation, 1 and Audrey P. Gasch, Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editingcorresponding author 1 , 2 ,*
Aaron P. Mitchell, Editor

Associated Data

Supplementary Materials
Data Availability Statement

Abstract

Aneuploidy produces myriad consequences in health and disease, yet models of the deleterious effects of chromosome amplification are still widely debated. To distinguish the molecular determinants of aneuploidy stress, we measured the effects of duplicating individual genes in cells with different chromosome duplications, in wild-type cells (SSD1+) and cells sensitized to aneuploidy by deletion of RNA-binding protein Ssd1 (ssd1Δ). We identified gene duplications that are nearly neutral in wild-type euploid cells but significantly deleterious in euploids lacking SSD1 or in SSD1+ aneuploid cells with different chromosome duplications. Several of the most deleterious genes are linked to translation. In contrast, duplication of other genes benefits multiple ssd1Δ aneuploids over controls, and this group is enriched for translational effectors. Furthermore, both wild-type and especially ssd1Δ aneuploids with different chromosome amplifications show increased sensitivity to translational inhibitor nourseothricin. We used comparative modeling of aneuploid growth defects, based on the cumulative fitness costs measured for single-gene duplication. Our results present a model in which the deleterious effects of aneuploidy emerge from an interaction between the cumulative burden of many amplified genes on a chromosome and a subset of duplicated genes that become toxic in that context. These findings provide a perspective on the dual impact of individual genes and overall genomic burden, offering new avenues for understanding aneuploidy and its cellular consequences.

Author summary

Aneuploidy, when cells carry an imbalanced set of chromosomes, creates cellular defects relative to euploids, but the molecular causes of these deleterious effects are not known. One possibility is that having an entire extra chromosome of gene products is inherently stressful to cells; another is that extra copies of specific individual genes are highly toxic. In this study, we investigate aneuploidy stress in yeast by duplicating individual genes in euploids and aneuploids in a wild yeast model, and identify that some genes with little effect in one context are uniquely deleterious in the other. We use modeling to show that context-dependent gene toxicity helps explain aneuploidy defects and that cells with extra chromosomes may have a vulnerability linked to translation.

Introduction

Aneuploidy, the state of having an abnormal number of one or more chromosomes, is highly relevant to human health: it underlies embryonic inviability and trisomy syndromes, is associated with aging, and is a well-known feature of malignant cancers [13]. Debates continue over the mechanisms driving the deleterious consequences of aneuploidy, specifically the negative effects of chromosome duplication. Models range from focusing on the increased generic burden of extra DNA and encoded protein [4,5], to stoichiometric imbalance of dosage-sensitive proteins [68], to amplification of specific highly toxic gene products [9,10]. However, distinguishing between the deleterious effects of specific genes versus the collective burden of many genes is a significant experimental challenge, especially in mammalian systems. Thus, despite the relevance and prevalence of aneuploidy, we still lack a comprehensive understanding of the mechanisms behind the deleterious consequences of chromosome amplification.

Research in the yeast model organism, Saccharomyces cerevisiae, has expanded our understanding of the cellular impacts of aneuploidy and led to the discovery of key genetic vulnerabilities. Pioneering studies using the highly aneuploidy-sensitized laboratory strain W303 unveiled a range of defects in cells with extra chromosomes. These include metabolic changes, cellular stress, defects in cell-cycle progression, and signs of protein aggregation and protein mismanagement known as proteostasis stress [4,1115]. However, work from our lab and others has shown that the W303 is an outlier in its extreme sensitivity to chromosome duplication. In contrast to the W303 strain, aneuploidy is not uncommon in non-laboratory strains of yeast and found in ~20% of strains distributed across the S. cerevisiae phylogeny [16,17]. Strains with extra chromosomes typically grow substantially better than W303, though often with slower growth rates than isogenic euploid cells, in both wild yeast strains and a different lab strain derived from S288c [1620]. We previously showed that the W303 strain’s extreme sensitivity to chromosome duplication is due to a hypomorphic allele of the RNA-binding protein Ssd1 [21]. Deletion of SSD1 from wild strains recapitulates many of the aneuploidy phenotypes reported in W303, including signs of proteostasis stress [21]. Ssd1 is thus a key mediator of aneuploidy tolerance, though its precise role in this modulation has remained elusive.

Ssd1, orthologous to human Dis3L2 but lacking nuclease activity, binds several hundred mRNAs via sequence motifs often found in the 5’ UTR [2126]. Bound mRNAs are enriched for a variety of encoded functions, including proteins localizing to the cell wall and proteins involved in cell cycle regulation, RNA metabolism, sterol transport, and a diverse collection of seemingly unrelated functions [21,22,24]. Although molecular details are sparse, Ssd1 plays a role in translation and localizing mRNAs to processing bodies and the cellular periphery, particularly for encoded proteins localized to the cell wall or nascent bud [22,23,2631]. Recent findings from our laboratory demonstrated that deleting SSD1 sensitizes a wild strain to most chromosome duplications to varying degrees [32], indicating that the role of Ssd1 in aneuploidy tolerance is not limited to a specific chromosome. Thus, understanding the role of Ssd1 in tolerating chromosome amplification is a potent tool for investigating the molecular determinants of aneuploidy tolerance more broadly.

Separate from the role of Ssd1, the molecular determinants behind aneuploidy toxicity in functional cells are still widely debated. Work from S. cerevisiae transformed with yeast artificial chromosomes (YACs) containing human DNA implicated gene products—not merely the presence of extra DNA—as the cause of aneuploidy-related defects [4,33]. This fostered the idea that proteostasis stress resulting from many amplified genes drives aneuploidy toxicity in sensitized cells [11,34]. One hypothesis is that simply having too much protein, regardless of what the proteins are, produces proteostasis stress. But another is that the over-abundance of specific proteins causes stoichiometric imbalance. Focus has landed on proteins in multi-subunit complexes and those with many protein-protein interactions, since these may be most affected by stoichiometry [7,35,36]. Both cases could cause a range of effects including protein aggregation [37], defects with protein quality control [11], and resulting osmotic challenges that disrupt endocytosis and other processes [38]. An alternate theory is that amplification of specific genes encoded on some chromosomes could pose particular problems. Given that whole chromosome amplification inherently increases the copy number of many genes simultaneously, distinguishing the effects of specific genes from generalized burden remains a complex task.

In this study, we leveraged Ssd1 to help distinguish between these possibilities. We used a yeast gene expression library to identify genes that are deleterious when duplicated in isolation, in euploid and aneuploid cells with and without SSD1 (referred to as SSD1+ and ssd1Δ, respectively). Assaying euploids and aneuploids enabled us to identify differential effects of gene duplication in both contexts. This approach identified shared susceptibilities in ssd1Δ euploid cells and SSD1+ aneuploids, revealing that SSD1 deletion in euploids partly phenocopies the stress of aneuploidy in wild-type cells. We propose that the stress of chromosome duplication results from an interaction between the generalized burden of chromosome amplification with specific genes whose duplication is largely neutral in euploid cells but becomes problematic in the aneuploid context. Our study demonstrates the value of leveraging genetic vulnerabilities to deepen our understanding of the cellular state of aneuploidy and its implications for human health.

Results

We set out to investigate the response of ssd1Δ cells to chromosome duplication. We leveraged a recent study from our lab that generated a panel of haploid Saccharomyces cerevisiae strains, each carrying an extra copy of single chromosomes [32]. This strain panel was engineered in a haploid derivative of oak-soil strain YPS1009 and included all chromosomes except chromosome VI (Chr6) that is toxic [4,39]. That work also generated a comparable panel in YPS1009 cells lacking SSD1, excluding Chr16 duplication that was unculturable in the absence of Ssd1. We previously observed that many of the aneuploid strains showed reduced growth rates in the absence of SSD1, although the models of Ssd1 involvement were not pursued further [32]. Here, we specifically analyzed the growth rates of ssd1Δ aneuploids to better understand how Ssd1 is involved in aneuploidy tolerance.

At the outset, we envisioned two possibilities for Ssd1’s role. One possibility is that Ssd1 manages the stress of chromosome duplication seen in wild-type cells, such that deletion of SSD1 exacerbates that stress. If so, the degree of Ssd1 dependence for each chromosome duplication would be proportionate to the fitness cost of that chromosome duplication in the wild type. This should produce a linear relationship between Ssd1 dependence and inherent chromosome fitness costs. An alternative possibility is that deletion of SSD1 introduces entirely new sensitivities that are not relevant in the SSD1+ aneuploids. In this scenario, the degree of Ssd1 dependence may be uncorrelated with chromosome toxicity in the wild-type cells.

To distinguish these possibilities, we plotted Ssd1 dependence against the fitness cost of each chromosome. We defined the Ssd1 dependence of each chromosome as the relative growth rate of the ssd1Δ aneuploid versus the wild-type aneuploid with the same chromosome duplication. We then plotted this against the relative growth rate of each wild-type aneuploid versus the euploid control (Fig 1). We found a modest yet significant correlation between Ssd1 dependence and chromosome fitness cost (R2 = 0.41, p = 8.3E-03). However, several chromosome amplifications were substantially more or less dependent on Ssd1 than predicted from the chromosome cost in the wild type. For example, tolerance of Chr12 duplication was very dependent on Ssd1, surpassed only by Chr16 duplication that is unculturable in the ssd1Δ strain. Conversely, Chr2, Chr14, and Chr10 amplifications were proportionately less dependent on Ssd1 than expected. Together these findings imply that Ssd1 has a generalizable role in coping with aneuploidy, but with some chromosome-specific effects. Thus, Ssd1 deletion is a useful tool to exacerbate and interrogate the stress of chromosome duplication.

An external file that holds a picture, illustration, etc.
Object name is pgen.1011454.g001.jpg
Ssd1 dependence is modestly correlated with aneuploidy toxicity in the SSD1+ wild-type background.

The y-axis shows the Ssd1 dependence of each chromosome duplication, taken as the average (n = 4) growth rate of the ssd1Δ aneuploid versus the average (n = 4) wild-type aneuploid. The x-axis shows the relative fitness of each aneuploid strain, taken as the average (n = 4) growth rate of wild-type aneuploid versus the corresponding average for the euploid. Growth rates were reported in [32]. Points are labeled to identify the amplified chromosome. The line shows ordinary least squares regression; shaded area denotes the 95% confidence interval (see Methods).

A gene expression library reveals costs of single gene duplication

Previous studies strongly suggested that aneuploidy toxicity is dependent on genes encoded on the amplified chromosomes, since large DNA segments without coding potential are not especially toxic in yeast [4,33]. But whether aneuploidy toxicity, and Ssd1 dependence in particular, is due to only a few specific genes or the cumulative burden of many genes was unclear. To distinguish between models and study Ssd1’s role in aneuploidy tolerance, we measured the cost of individual gene duplications, using a barcoded plasmid library (Fig 2A). The MoBY 1.0 gene library comprises ~5,000 open reading frames along with their native upstream and downstream sequences, cloned onto a barcoded centromeric (CEN) plasmid [40]. We transformed the library into wild-type and ssd1Δ euploid strains as well as select wild-type and ssd1Δ aneuploids with duplications of Chr4, Chr7, Chr12, and Chr15 (the Chr15 wild-type aneuploid was omitted due to poor library coverage). These strains were chosen because they present a range of growth defects and varying degrees of Ssd1 dependence. Each copy of the duplicated chromosomes carried a different selectable marker, allowing both copies of the chromosome to be maintained throughout the experiment. Each pooled library was grown for 10 generations (with the exception of the YPS1009 Chr4 ssd1Δ strain, which was grown for only 5 generations due to its extreme fitness defect), in at least 3 biological replicates (see Methods). An aliquot of the library was collected before and after competitive growth, and the relative abundance of each plasmid in each sample was scored by sequencing the plasmid barcodes (see Methods). Barcodes that decreased in abundance during competitive growth correspond to deleterious gene duplicates, whereas barcodes that increased in abundance represent genes whose duplication is advantageous. To quantify fitness effects, we calculated a fitness score for each gene duplication, defined as the log2(fold change) of normalized barcode counts after competitive growth (see Methods). We applied several types of comparisons to understand the impact of aneuploidy in SSD1+ and ssd1Δ cells (Fig 2B). Data for the euploid YPS1009 were first reported in a parallel paper from our lab [32].

An external file that holds a picture, illustration, etc.
Object name is pgen.1011454.g002.jpg
Distribution of fitness costs of gene duplication are similar in aneuploids and euploids.

A) Schematic of the approach, see text for details. B) Library competition experiments were performed in strains indicated in the diagram. Specific comparisons (indicated by a number) were made to compare: (1) Wild-type aneuploids versus wild-type euploid; (2) ssd1Δ euploid versus wild-type euploid; (3) ssd1Δ euploid versus wild-type aneuploids, used for modeling; (4) ssd1Δ aneuploids versus wild-type euploid, ssd1Δ euploid, and corresponding wild-type aneuploid when available. C) Distribution of fitness scores (log2(fold change) of normalized barcode counts) for all measured genes in euploid (Eu.) and aneuploids with the denoted chromosome amplification. D) Distribution of pairwise differences in log2 fitness scores between each wild-type aneuploid and batch-paired euploids (Comparison 1 in B), for 2,403 detrimental genes identified in the euploid wild-type [32]. EuB2-B1 represents a control distribution comparing fitness scores in two batches (B1 and B2) of euploid replicates. https://commons.wikimedia.org/wiki/File:Erlenmeyer_Flask_%2822792%29_-_The_Noun_Project.svg.

As reported in this parallel paper, duplication of 2,403 genes produced a significant fitness effect in the euploid strain at a false discovery rate (FDR) < 0.05 [32]. Re-analysis here showed that beneficial gene duplicates were enriched for essential genes (p = 9.1E-08, hypergeometric test). Genes whose duplication was detrimental were not enriched for any gene ontology terms; however, we previously noted that deleterious genes tended to be longer and encode proteins with more disorder [32], consistent with other reports [41]. There was no enrichment for proteins in multi-subunit complexes and no difference in the number of protein interactions for deleterious genes compared to neutral genes. None of the chromosomes showed a significant overrepresentation of detrimental genes that passed FDR significance (FDR > 0.05, hypergeometric test with Benjamini and Hochberg correction).

Aneuploid strains are not universally more sensitive to gene duplications

Here we focus on the effects of single-gene duplication in aneuploid strains. We initially hypothesized that aneuploids may be more sensitive to the gene duplication library, since they already carry a burden of extra gene content. If aneuploids were more sensitive to gene duplication, we would expect more deleterious genes in aneuploid strains and/or more severe fitness defects upon duplication. On a global scale, this was not the case: the proportion of detrimental genes was comparable between aneuploids and batch-paired euploids (see S1 Table), albeit with a marginally higher proportion of detrimental genes in aneuploids as seen in comparing the distributions (Fig 2C). This could not be explained by data normalization issues, since we confirmed that genes scored as neutral in the library experiment had no significant effect on growth rate when strains were grown in isolation (S1 Fig). Although there was a longer tail of genes with stronger negative effects in the aneuploid strains (Fig 2D), the bulk of the distribution was similar to euploids. We conclude that the aneuploid strains are not sensitized to over-expression of all genes, but they are overly sensitive to a subset of duplicated genes.

To investigate further, we identified 335 genes that were deleterious in one or more aneuploids (FDR < 0.05) with a fitness score at least 1.5 in log2 space more deleterious than batch-paired euploid measurements (Comparison 1 in Fig 2B, see Methods and S1 Data). Of these 335 deleterious gene duplicates, 58 were common to two or more aneuploid strains, suggesting common effects across aneuploid strains. There was no enrichment for any gene ontology terms. However, we noticed that 8 of the common detrimental genes are naturally encoded adjacent to a centromere, such that the centromere was cloned onto the plasmid along with the gene. Dicentric plasmids are known to be unstable in yeast [42], likely because spindle attachment to both centromeres results in DNA breakage [43]. The number of especially deleterious plasmids that carried a cloned centromere was higher than expected by chance (p = 5.5E-09, hypergeometric test). This raised the possibility that plasmids with multiple centromeres may be especially unstable in aneuploid strains relative to euploids.

In contrast, we noticed that some genes scored as deleterious in the euploid were much less deleterious in aneuploids (Fig 2D). We identified 360 genes that were deleterious in the euploid strain (FDR < 0.05) but at least 1.5 in log2 space less so in one or more wild-type aneuploids (Comparison 1 in Fig 2B and S1 Data). 153 of these genes were common to two or more aneuploid strains, again suggesting common effects independent of which chromosome is duplicated. Intriguingly, this group was enriched for genes involved in the mitotic spindle (p = 9.1E-05, hypergeometric test). Previous work by Storchova et al. [44] showed that a subset of genes affecting the mitotic spindle are essential in tetraploid, but not diploid, yeast. The authors proposed that increased chromosome content may alter requirements for spindle geometry for proper chromosome management. Our results hint that aneuploid cells with extra chromosomes may benefit from increased abundance of spindle components. In sum, our results suggest that aneuploid strains are not generally more sensitive to further gene duplication but that a subset of genes are more or less toxic in aneuploids.

Specific gene duplications are especially toxic in ssd1Δ euploids and explain a portion of Ssd1 aneuploidy dependence

As shown above, SSD1 deletion sensitizes cells to aneuploidy to varying degrees depending on which chromosome is amplified. Given Ssd1’s role in translational suppression, we wondered if SSD1 deletion sensitizes cells to gene over-production in general. We therefore used the library to measure fitness costs of single-gene duplication in the ssd1Δ euploid. Overall, the distribution of fitness scores for gene duplications was not significantly different than the euploid wild type (p = 0.38, Wilcoxon rank-sum test, Fig 3A), indicating that ssd1Δ does not sensitize cells to all gene duplications. We directly compared ssd1Δ euploid versus wild-type euploid cells (Comparison 2 in Fig 2B) and identified 218 genes more detrimental in the ssd1Δ euploid (FDR < 0.05, Fig 3B and S1 Data). We were especially interested in identifying functional or biophysical properties of these genes; however, the group did not have striking functional enrichments, aside from 4 genes involved in ER to Golgi transport (p = 1.7E-03, hypergeometric test). We tested more than a dozen other transcript or protein features including abundance, structure or sequence composition, or other biophysical properties, but found nothing significant (see Methods). Furthermore, the group was not enriched for mRNAs bound by Ssd1 (p = 0.67, hypergeometric test) or that harbor the known Ssd1 binding motifs [22,24]. Reciprocally, genes encoding Ssd1-bound mRNAs were not more deleterious when duplicated in the absence of SSD1 (Fig 3C). The only significant feature we found was that the length distribution of these 218 genes is shorter than all other genes in the dataset (p = 1.3E-04, Mann-Whitney U test). This is notable since genes whose duplication is deleterious in the wild type tend to be longer than neutral genes [32]. Thus, it is unclear why these 218 gene duplicates are more deleterious in ssd1Δ cells.

An external file that holds a picture, illustration, etc.
Object name is pgen.1011454.g003.jpg
A subset of genes are more detrimental in ssd1Δ euploid cells relative to wild type.

A) Distributions of fitness scores for all 4,462 measured genes in wild-type euploid and ssd1Δ euploid strains. B) Scatterplot of replicate-averaged fitness scores for all measured genes in ssd1Δ euploid (y-axis) and wild-type euploid (x-axis); 218 genes significantly more deleterious in ssd1Δ euploid cells are shown in pink. C) Fitness scores for 336 genes encoding mRNAs bound by Ssd1 (see Methods) in wild-type (blue) and ssd1Δ (light blue) euploid strains. D) Ssd1 dependence as shown in Fig 1 (y-axis) plotted against the predicted Ssd1 dependence, calculated as the sum of log2 gene-specific Ssd1 dependence values as described in the text (x-axis), over the subset of 218 genes whose duplication is toxic to ssd1Δ cells. E) Ssd1-dependent fitness scores for the 218 genes analyzed in (D), plotted according to encoding chromosome.

Nonetheless, we used these fitness scores to further understand models of Ssd1 dependence. In other recent work from our lab, we showed that nearly 70% of the variance in wild-type aneuploid growth rates can be explained by the cumulative fitness costs of genes duplicated on each chromosome [32]. Here we used a similar approach to explain Ssd1 dependence. We tested if the Ssd1 dependence for each chromosome duplication (as shown in Fig 1) could be explained by the cumulative Ssd1 dependencies of genes duplicated on that chromosome. We calculated Ssd1 dependence for each gene as the fitness cost for that gene duplication in the ssd1Δ strain versus the fitness cost for that gene duplication in the SSD1+ euploid strain. We then calculated the per-chromosome Ssd1 dependence as the sum of relative log2 fitness scores over the 218 genes more deleterious in the mutant strain (see Methods). This simple model explained roughly half of the variance in Ssd1 aneuploidy dependence, with an adjusted R2 of 0.46 (Fig 3D, p-value = 3.2E-03). Omitting Chr16 from consideration increased the explanatory power to 51% (adj. R2 0.51). Model performance decreased when only the top 10% of ssd1Δ -sensitive genes were used (36% of variance explained, S2 Fig). Thus, Ssd1 dependence for tolerating chromosome duplications can be partly explained by the cumulative burden of specific genes on each chromosome; however, this number is more than one or two genes per chromosome (Fig 3E).

Many gene duplicates toxic in ssd1Δ euploids are also toxic to SSD1+ aneuploids but not SSD1+ euploids

Ssd1 is required to tolerate specific gene duplications, although the reasons are unclear. We wondered if SSD1+ aneuploids may be sensitive to the same set of genes. We explored this in several ways. First, we realized that genes more deleterious in one or more aneuploid strains (Comparison 1 in Fig 2B) are enriched for the 218 genes whose duplication is especially deleterious in ssd1Δ euploid cells (Comparison 2 in Fig 2B, p = 2.9e-06, hypergeometric test). Second, we interrogated the fitness scores of these 218 genes in wild-type aneuploid cells. We plotted the average fitness scores from the three wild type aneuploids against the euploid fitness scores for these 218 genes (Fig 4A). Indeed, 145 (67%) of these genes were more deleterious in aneuploids than in the euploid. One subset of genes was especially more toxic in aneuploids, indicated by their deviation from the linear trend (Fig 4A, labeled points). We confirmed that these genes were more deleterious in individual aneuploids compared to the euploid (Fig 4B). Thus, many of the gene duplications that are toxic in ssd1Δ euploids are also more deleterious in SSD1+ aneuploids versus the euploid. This indicates that aneuploidy may be mimicking the cellular state of ssd1Δ euploid cells (see Discussion).

An external file that holds a picture, illustration, etc.
Object name is pgen.1011454.g004.jpg
Many gene duplications toxic in ssd1Δ euploids are also toxic in SSD1+ aneuploids.

A) Average wild-type aneuploid fitness scores for each gene (y-axis) plotted against the corresponding fitness score measured in wild type euploid cells (x-axis), for the 218 genes in Fig 3B. Genes with especially deleterious effects in aneuploids relative to the euploid are labeled with gene name. B) Fitness scores for genes labeled in Fig 4A (rows) in biological replicates of each strain (columns), colored according to the key. C) The relative fitness of aneuploid strains (as in Fig 1) was plotted against the predicted relative fitness, taken as the sum of log2 fitness values for the 218 gene duplicates as measured in the ssd1Δ euploid strain (x-axis).

We wondered how well the cumulative cost of these 218 gene duplicates, identified by their sensitivity in the ssd1Δ euploid, could explain chromosome fitness costs in SSD1+ aneuploids. We calculated the fitness cost of each chromosome duplication in SSD1+ cells as the cumulative cost of these 218 gene duplicates, based on measurements from the wild-type euploid strain (see Methods). The calculated fitness costs did not agree with the measured costs in the SSD1+ background (adjusted R2 = 0.07, p-value = 0.18). However, many of these genes are only deleterious when duplicated in the ssd1Δ euploid strain. This raised the possibility that the fitness costs of these gene duplicates in the ssd1Δ euploid was most relevant. We therefore modeled the fitness cost of chromosome duplication in SSD1+ cells, but based on gene fitness costs measured in the ssd1Δ euploid strain. Remarkably, this model explained 73% of the variance in growth rates of the SSD1+ aneuploids (Fig 4C). This important result indicates that chromosome duplication in an SSD1+ background may mimic the liabilities of SSD1 deletion in a euploid strain, sensitizing cells to the same subset of problematic gene duplications (see Discussion).

Duplicated genes beneficial in ssd1Δ aneuploids implicate mechanisms of aneuploidy tolerance

Since SSD1 deletion sensitizes strains to the stress of chromosome duplication, we wondered if genes beneficial in ssd1Δ aneuploids might complement processes that are defective in those aneuploids. We therefore identified genes whose duplication compensates growth defects in ssd1Δ aneuploids under the conditions used here (Comparison 4 in Figs Figs2B2B and 5A5A). There were 445 genes whose duplication was beneficial to at least one ssd1Δ aneuploid strain (FDR < 0.05) and that displayed a higher fitness score than observed in corresponding wild-type aneuploids and both euploids (see Methods and S1 Data). We identified the greatest number of beneficial genes in ssd1Δ cells with an extra copy of Chr12, possibly due to increased statistical power from 4 replicates (but perhaps also influenced by the rDNA locus on this chromosome [83]), followed by ssd1Δ Chr4 aneuploid cells. The fewest beneficial duplications were found in the ssd1Δ Chr7 aneuploid, which is the least dependent on Ssd1 of the aneuploids studied here. To validate, we tested 13 plasmids expressed in Chr12 aneuploids; 8 of the 13 genes significantly improved growth in the ssd1Δ aneuploid relative to empty vector, confirming library measurements (S3A Fig).

An external file that holds a picture, illustration, etc.
Object name is pgen.1011454.g005.jpg
Gene duplications that benefit ssd1Δ aneuploids implicate translation.

A) Hierarchically clustered fitness scores for 445 gene duplications (rows) beneficial in at least one aneuploid strain (columns), colored according to the key. Fitness scores represent the average of at least biological triplicate. (*) denotes scores measured after 5 generations instead of 10 generations, see text. B) Venn diagram of beneficial genes identified in ssd1Δ aneuploids. Dotted border identifies beneficial genes common to 3 or more ssd1Δ aneuploids. The inset lists 18 genes identified in 3 or more ssd1Δ aneuploids; bolded genes have known links to translation. C) Average and standard deviation of relative growth rates of the denoted strains grown in 1ug/mL nourseothricin (NTC) compared to a water control (n = 3). Measured growth rates are indicated as solid bars; expected growth rates based on the combined effect of NTC and underlying aneuploidy growth defect are shown as dashed bars (see Methods). (**) p-value < 0.01, (*) p < 0.05, (+) p < 0.1, one-tailed paired T-test.

Comparing across strains revealed that many gene duplications were beneficial to multiple ssd1Δ sensitized aneuploids (Fig 5B, see Methods). We were especially interested in these genes, which may point to processes that are generally compromised upon chromosome duplication. 98 of these gene duplications showed positive fitness scores in at least 2 aneuploids, and 18 duplications were positive in at least 3 aneuploids. The group of 98 was enriched for genes encoding small GTPase-mediated signaling proteins (p = 3.7E-05, hypergeometric test) and mRNA processing proteins (p = 9.8E-04), while the group of 18 was enriched for translational regulators (p = 1.1E-03, hypergeometric test). Somewhat surprisingly, we did not find enrichment of genes linked to protein folding or the ubiquitin-proteasome system, which were previously associated with aneuploidy tolerance in the ssd1- W303 strain [45]. Of the five plasmids with positive fitness scores in all four aneuploid ssd1Δ strains, four encode proteins directly implicated in translational regulation: poly-A binding protein Pab1, translational repressor Sbp1, and eIF5a elongation factor Hyp2, which was cloned along with uncharacterized gene UTR5 on two of the selected plasmids. The fifth gene, GLC7, encodes PP1 phosphatase that can act on translational regulator eIF2a in yeast [46], as well as on other proteins. We confirmed that PAB1, SBP1, and HYP2/UTR5 all significantly improve growth rates of ssd1Δ Chr12 aneuploid cells relative to empty vector (p < 0.05, S3A Fig). We tested the HYP2/UTR5 plasmid in other strains and found that it also benefited ssd1Δ with Chr4 duplication and, to a minor degree that just missed significance (p = 0.08), the ssd1Δ strain with Chr7 duplicated (S3 Fig).

We performed a similar analysis for the wild-type aneuploids, and identified 66 genes that provided a benefit to two or more wild-type aneuploids relative to batch-paired euploid (S1 Data). Interestingly, ten of these genes overlap the 98 genes that were beneficial to multiple ssd1Δ aneuploids (S4 Fig). One of these was poly-A binding protein encoded by PAB1—indeed, duplication of PAB1 provided a mild but significant benefit to the tested wild-type YPS1009_Chr12 strain (S3A Fig).

Deleterious gene duplicates are also involved in translation

In retrospect, we realized that several of the genes whose duplication was especially deleterious in ssd1Δ euploid and wild-type aneuploid cells are also connected to translation (Fig 4). Among those genes was OAZ1, which encodes an anti-enzyme that negatively regulates polyamine synthesis [47]. Polyamines are precursors of hypusine, a non-canonical amino acid required for Hyp2 function [4748, reviewed in 49]. Oaz1 production is regulated via a programmed ribosomal frameshift as well as a programmed ribosome stall [47,50], which together serve as readouts of translational fidelity that is in part dependent on Hyp2 [51]. Overproduction of Oaz1 is expected to indirectly inhibit Hyp2 function by downregulating the synthesis of polyamines required for hypusination. Intriguingly, OAZ1 is encoded on Chr16, whose duplication is essentially inviable in the ssd1Δ background. Several other genes from Fig 4B are also linked to these processes: SAM3 involved in S-adenosylmethionine (SAM) and polyamine transport [52], MTQ1, a SAM-dependent translational regulator [53], and RPG1, a subunit of eIF3 with roles in translation reinitiation as well as stop codon readthrough [54,55]. Together, these links reinforce the idea that under the conditions studied here, ssd1Δ aneuploid strains and, to a lesser extent wild-type aneuploids, may have defects related to translation.

Our previous work showed that the Chr12 aneuploid and especially ssd1Δ Chr12 aneuploid without the drug-resistance cassette are sensitive to low doses of nourseothricin (NTC) [21], a translation-elongation inhibitor that at low doses stalls ribosomes, induces tRNA misincorporation and produces protein misfolding [56,57]. To test if this is a generalizable feature of aneuploid strains, we investigated other chromosome duplications for sensitivity to NTC. Indeed, all SSD1+ aneuploids without the drug-resistance gene grew significantly slower than expected based on an additive genetic model of aneuploidy and NTC effects (p < 0.05, replicate-paired t-test, Fig 5C, see Methods) except the Chr7 aneuploid, which missed the significance cutoff. On the other end of the spectrum, duplication of the highly Ssd1-dependent Chr16 produced the greatest sensitivity to the drug. All of the ssd1Δ aneuploids treated with NTC grew reproducibly slower than expected across all replicates. Importantly, the ssd1Δ euploid shows no sensitivity to NTC, indicating a genetic interaction between SSD1 deletion and extra chromosomes. Together, the sensitivity to NTC implicates translation as a particular vulnerability of wild-type aneuploids, which is exacerbated in the absence of SSD1.

One consideration is if the genes identified as beneficial in our study are related to residual effects of aminoglycoside antibiotics used in our library selection, even though strains carry the resistance genes. The library selection was done in the presence of G418 to maintain the plasmid library and nourseothricin to maintain the extra chromosome. It is possible that remaining sensitivity to NTC or G418 persists even when cells harbor the drug-resistance markers. To investigate, we performed several controls (S5 Fig). To the extent that we can detect, aneuploids with the G418 resistance marker did not show appreciable G418 sensitivity, with the exception of slightly reduced growth of the ssd1Δ Chr4 aneuploid that is already extremely slow growing. This was important, because validation of beneficial genes was done in the presence of G418 selection (without additional NTC). Furthermore, of two sets of strains tested (wild-type and ssd1Δ strains with extra Chr12 or Chr15), none of the strains with the NTC resistance cassette were sensitive to NTC under the conditions studied here. We also compared library results from this study to another recent study from our lab investigating the Chr12 aneuploid with the Moby 1.0 library grown in the absence of NTC (G418 was still required to maintain the library) [58]. Despite experimental differences, the results were highly similar between the two studies (S5C and S5D Fig), including the wild-type aneuploid sensitivity to the 218 genes shown in Fig 3B. We note that these genes were identified by their deleterious effects in the ssd1Δ euploid, which shows no sensitivity to aminoglycoside drugs. Finally, our validation experiments to test beneficial effects of individual plasmids (S4 Fig) was done in rich medium without NTC. Thus, while it remains possible that the beneficial genes identified here are influenced by unrecognized residual drug sensitivity of strains with the drug-resistance genes, our results together implicate a liability of aneuploid cells related to translation.

Discussion

Although a rich body of literature describes phenotypes associated with chromosome duplication, the molecular causes of those phenotypes and aneuploidy toxicity in general remain poorly understood. Previous studies suggest that the products of amplified genes are to blame [4], but whether this is due to specific products and their associated properties or functions, or to a general burden associated with the increased genic load had been unknown. Many studies of Down syndrome (DS) focus on single genes amplified on human chromosome 21 [9,10], and the effects of these genes are often studied via duplication in isolation in euploid tissue culture. On the other hand, several lines of evidence instead implicate the generalized burden of aneuploidy, independent of which chromosome is amplified. For example, Bonney et al. [5] found that extra copies of a few dosage-sensitive genes expressed on each chromosome were not sufficient to explain reduced proliferation of aneuploids in a sensitized laboratory strain. Several other studies emphasize consequences of aneuploidy that are karyotype-independent [4,11,13,14,38,5961]. Many perspectives suggest that it is some combination of the two models, where deleterious genes on each chromosome combine with increased sensitivity of aneuploid strains that have an increased underlying burden on cellular systems.

Our results provide evidence for an important and distinct model: that the generalized burden of chromosome duplication sensitizes cells to the duplication of genes that are not deleterious on their own but become so in the aneuploid context. This model posits a genetic interaction between generalized and gene-specific effects of chromosome duplication in SSD1+ cells. We propose that the generalized effect of chromosome amplification mimics to some degree the vulnerability of ssd1Δ euploid cells to specific gene duplications. This hypothesis suggests that the physiological limitations of ssd1Δ cells, including those related to translation (and perhaps other things), are also at play in SSD1+ aneuploids.

Several lines of evidence support this model. On the one hand, we found that the growth defects incurred by chromosome duplication, in both wild-type and ssd1Δ cells, can be partly explained by a subset of toxic gene duplicates. Importantly, this group does not represent the most problematic genes in the wild-type euploid. In fact, many of these genes are near-neutral when duplicated in the euploid. Instead, the cellular context created by SSD1 deletion, or by chromosome amplification in SSD1+ cells, induces a specific vulnerability that renders these duplications toxic. It is possible that this sensitivity is amplified by the selection conditions used here (see S5 Fig). Nonetheless, we hypothesize that this vulnerability in aneuploid strains emerges from the cumulative effect of amplifying many genes at once [32]. Our model—that particular gene duplicates become problematic in the context of aneuploidy—has important implications for studies on aneuploidy toxicity, including the etiology of human aneuploidy syndromes. For example, many DS studies investigate the impact of human-chromosome 21 genes by duplicating them individually in euploid cell lines [6266]. Our results raise caution about modeling aneuploid phenotypes in euploids without considering the cellular context of aneuploidy.

Despite these important insights, several unanswered questions remain. Why do certain gene duplicates become deleterious in the aneuploid context and what is the role of Ssd1 in managing them? Among the 218 gene duplications especially deleterious in ssd1Δ euploid cells, the only shared signature we identified is that many are shorter than other genes. Short transcripts associate more with “closed loop” factors involved in mRNA circularization, which facilitates faster translation reinitiation [67,68]. This could be related to translational effects discussed below. Notably, we did not find these Ssd1-dependent genes to be more highly expressed at the RNA or protein level, nor did we find overrepresentation of genes encoding protein complexes, proteins with many protein-protein interactions, or proteins with a high propensity for disorder (see Methods). Work from our lab and others [32,69] strongly suggest that genes encoding multi-subunit complexes are not toxic when merely duplicated, likely because cells have evolved mechanisms to manage their moderate increase [16,32,70,71]. Therefore, the harmful effects identified in this study likely arise from unrecognized attributes, necessitating more research to investigate further.

Additionally, the mechanism by which Ssd1 influences these genes’ toxicity, if not directly regulating their mRNAs, remains unclear. Ssd1 interacts physically with the ribosome and other proteins that regulate translation (including Pab1 identified above as beneficial to ssd1Δ aneuploids) [72,73]. It also directly binds hundreds of mRNAs through direct contact [24]. One possibility is that Ssd1 has a general role in translation at many more mRNAs than those bound through direct contact. But another possibility is that misregulation of transcripts bound directly by Ssd1 triggers secondary, widespread consequences on translation dynamics or fidelity, resulting in toxic effects at other duplicated genes. Precedence exists for this situation. For instance, Aviner et al. [74] demonstrated that the ribosome collisions on mutant Huntington transcript produce a cycle of dysfunction that sequesters eIF5a. This sequestration depletes eIF5a from other transcripts, altering translation of stress-responsive transcripts, in part by misregulating their upstream open reading frames (uORFs). Interestingly, Ssd1 has also been linked to transcripts with uORFs [75], although we found no enrichment for known uORFs among the 218 genes identified here. Nonetheless, this example demonstrates how altered regulation of Ssd1 targets could indirectly render a different set of gene duplicates toxic in that context.

We propose that aneuploidy creates a context in which translational efficiency and/or fidelity is perturbed. Several lines of evidence support this hypothesis. First, both the sensitized lab strain and wild strains lacking SSD1 are highly sensitive to translation inhibitors including NTC—but only in the context of extra chromosomes [4,21,45]. This is consistent with a role for Ssd1 in translation, and suggests that Ssd1 is required to manage translational stress in aneuploid cells [26,30]. But wild-type aneuploids with functional SSD1 (and lacking the NTC resistance gene) are also more sensitive to NTC than euploid strains [21], suggesting that a vulnerability to translational stress exists also in SSD1+ cells. Studies in other organisms show that translational efficiency is also perturbed in response to monosomy, apparently driven by imbalanced expression of ribosomal proteins [76,77]. Thus other types of karyotype imbalance could also perturb global translation. Another line of evidence is that duplication of several genes involved in translation ameliorates the growth defect of ssd1Δ aneuploids, at least under the conditions used here. Finally, several recent studies from our lab (including those that use no aminoglycosides) identified other genes involved in translation that influence aneuploidy phenotypes, including genes linked to translational repression, P-body formation, and ribosome quality control [58,78]. Thus, mounting evidence points to a liability in translation in aneuploid yeast.

Several of these translational modifiers are implicated in tRNA misincorporation, which can lead to protein errors. An intriguing idea is that aneuploidy-induced translational stress provides the unrecognized source of proteostasis stress in aneuploid cells. Once again, Ssd1 may aid in generating hypotheses. Strains containing an SSD1 hypomorph are more vulnerable to defects in the Elongator complex, which is essential for chemically modifying specific tRNA [29]. Lack of these modifications results in tRNA misincorporation, frameshifting, and increased protein aggregation [7982]. That Ssd1 is linked to Elongator function and required for NTC tolerance (although only in the presence of extra chromosomes) suggests a role for Ssd1 in this process. We previously showed that NTC treatment of SSD1+ aneuploids mimics signatures of protein aggregation found in ssd1Δ aneuploids [21]. Thus, exacerbating translational defects in aneuploid cells, through NTC treatment or SSD1 deletion, may further overwhelm protein folding and maintenance systems leading to compromised proteostasis. Investigation of precisely how translational regulation intersects with proteostasis in aneuploids represents a fruitful area of ongoing inquiry.

Materials and methods

Strains and growth conditions

Further information about aneuploid panel, including strains and growth rates measured under standard conditions, can be found in [32]. All other strains used in this study are listed in S2 Table. In order to maintain aneuploidy over long-term growth, NATMX and His3MX6 were integrated by homologous recombination in the intergenic regions indicated in S2 Table, such that the two copies of the duplicated chromosome contained one or the other marker. Strains used in gene duplication experiments were transformed with a pool of the molecular barcoded yeast ORF library (MoBY 1.0) containing 5,037 barcoded CEN plasmids [40]. At least 25,000 transformants were scraped from agar plates for > fivefold replication of the library, and frozen glycerol stocks were made. Multiple independent transformations of the pooled library were performed for each strain (see competitive growth details below). Competitive growth was done in liquid synthetic media lacking histidine (SC-His) and with NTC (Werner BioAgents and Jena Bioscience, 100 mg/L) to maintain aneuploidy and G418 (Research Products International, 200 mg/L) for plasmid selection. We confirmed that most aneuploids are not sensitive to these drugs when they carry the drug-resistance cassette (S5 Fig). Experiments interrogating single genes were performed in rich YPD medium with G418 but in the absence of NTC in test tubes at 30°C with shaking. Strains to be compared were grown side-by-side in each replicate, allowing replicate-paired T-tests for statistical analysis. For NTC experiments in Fig 5C, cells were cultured in rich YPD medium for 3 hours into log phase; 1ug/mL NTC or an equivalent volume of water (vehicle control) were added; OD600 measurements were recorded beginning 1 hour after NTC addition. The observed growth rates for NTC-treated wild-type aneuploids was compared to the expected growth rates, calculated as the product of the no-NTC aneuploid growth rate and the % growth-rate reduction in the euploid treated with NTC. The observed growth rates for NTC-treated ssd1Δ aneuploids was compared to the expected growth rate, taken as the product of the % growth-rate reduction in the ssd1Δ aneuploid versus corresponding wild-type aneuploid in the absence of NTC treatment (the ssd1Δ effect) and the % growth-rate reduction in the NTC-treated wild-type aneuploid responding to NTC (the NTC effect).

MoBY 1.0 competitive growth

Competition experiments were performed as in [40,83]. Briefly, 1 mL frozen glycerol stocks of library transformed cells were thawed into 100 mL of liquid SC-His with NTC (100 mg/L) and G418 (200 mg/L) at a starting OD600 of 0.05, then grown in shake flasks at 30°C with shaking. An aliquot of frozen stock represented the starting pool (generation 0) for each strain. After five generations, each pooled culture was diluted to an OD600 of 0.05 in fresh media to maintain cells in log phase. At 10 generations (5 generations where indicated) cells were harvested and cell pellets were stored at −80°C.

Data were collected in two batches. Batch 1 data were generated from two independent competitive growths from each of two independent transformations of the plasmid library, for a total of 4 replicates. Reproducibility of fitness scores was consistently high between independent growths from the same transformation stock (Pearson correlation coefficients PCC 0.87–0.96) and more modest across independent growths from different transformation stocks (PCC 0.44–0.67). Thus, to capture this variation, Batch 2 included three independent competition experiments, each from a different transformation of the pooled library. This ultimately yielded noisier fitness scores but greater confidence in reproducible effects. We pooled euploid controls from Batch 1 and Batch 2 for 7 replicates each of the wild-type euploid [32] and ssd1Δ euploid experiments. Fitness scores generated from Batch 1 and Batch 2 were reproducible, with PCC of 0.93 and 0.92 for wild-type euploid and ssd1Δ euploid, respectively.

MoBY 1.0 sequencing

Plasmids were recovered from each pool using Zymoprep Yeast Plasmid Miniprep II (Zymo Research D2004-A). Plasmid barcodes were amplified using primers described in [84] and 20 PCR cycles. Barcode amplicons were pooled and purified using AxyPrep Mag beads (1.8X volume beads per sample volume) according to the manufacturer’s instructions (Axygen). Pooled amplicons were sequenced on one lane of an Illumina HiSeq 4000 to generate single-end 50 bp reads. Reads were mapped to 4,872 unique upstream tags (barcodes) [40]. This resulted in 126.2 million reads with exact matches to MoBY 1.0 barcodes in Batch 1 across 32 samples (average of ~3.9M reads/sample) and 154.7 million reads in Batch 2 across 51 samples (average of ~3.0M reads/sample). Sequencing data and barcode counts are available in the Gene Expression Omnibus (GEO) under accession GSE263221.

MoBY 1.0 dataset analysis

To limit bias from barcodes that were under-represented in the starting pool, we removed barcodes in the bottom 5% of total counts at generation zero or with 0 reads across all samples (n = 303 for Batch 1 comparisons, n = 338 for Batch 2 comparisons, n = 313 for integrated comparisons across all 7 euploid replicates). A pseudocount of 1 was added to every measurement, and resulting data were normalized by TMM normalization [85] in edgeR version 3.36.0 [86]. TMM normalization produced very similar results to normalization by total barcodes sequenced. Barcodes that changed significantly in abundance in each experiment (i.e. after 10 generations of outgrowth compared to each starting pool) were identified using a glmQ function in edgeR with quasi-likelihood tests, using Benjamini and Hochberg multiple test correction and taking a false discovery rate (FDR) < 0.05 as significant [87]. A small number of genes cloned on multiple plasmids, and thus reported with multiple barcodes, were removed from downstream analysis. In total, barcodes representing 4,508 genes were analyzed across the two batches of experiments, interrogating indicated aneuploids and batch-paired euploids. Fitness scores correspond to the average log2(fold change) reported in edgeR output files. Hierarchical clustering was performed using Cluster 3.0 [88] and visualized using Java TreeView [89]. 5 generation collections (Chr4 ssd1Δ, Chr4 wild-type, and isogenic euploids) were analyzed separately. To maximize available statistical power, we combined and reanalyzed all wild-type and ssd1Δ euploid replicates from Batch 1 and Batch 2 (referred to as “integrated analysis”).

Enrichments

Enrichments for GO terms were assessed using setRank version 1.0 [90] or GO Term Finder version 0.86 in the Saccharomyces Genome Database [91], comparing to a background dataset of all measured genes. Statistical significance was assessed using Mann-Whitney U tests for continuous data and hypergeometric tests for categorical terms. DNA motif searches were performed on sequences -500 bp upstream and +100 bp downstream each gene’s open reading frame, using MEME suite [92] for novel motif discovery and SEA [93] to look for enrichment of genes whose upstream regions harbor previously identified motifs associated with Ssd1 binding, AKUCAUUCCUU and CNYUCNYU, respectively [22,24]. Propensity for disorder was quantified by % residues with IUPRED3 disorder propensity score >0.5 [94]. Ssd1 targets were compiled from [21,24]; the Bayne et al. targets comprise the 189 targets identified at 30 degrees C as at least 2-fold enriched at FDR < 0.05 [24]. Other mRNA/protein features as listed in [32] were analyzed as outlined in that study, along with age-dependent ribosome pause sites from [95,96]. None of those features aside of what is listed in the main text showed statistical significance.

Modeling

Linear modeling was performed using ordinary least squares (OLS) regression as implemented in the statsmodels version 0.11.1 package for python3. Visual representations of the regressions were created using seaborn version 0.11.2, with 95% confidence interval plotted using the lmplot function. Predicted Ssd1 dependence (Figs (Figs11 and and3D)3D) or predicted aneuploid fitness relative to the euploid (Fig 4C) were taken as the sum of scores for genes indicated in each figure legend that are on each chromosome.

Identifying detrimental/beneficial gene sets

Unless otherwise noted, detrimental/beneficial gene sets correspond to barcodes with statistically significant decreases/increases in abundance (log2(fold change) < 0 or > 0, respectively, and FDR < 0.05). The 218 genes described in the text were identified comparing 7 replicates each of wild-type and ssd1Δ euploid selections (FDR < 0.05). Genes more detrimental in wild-type aneuploid versus euploid were those with a negative log2 fitness score at FDR < 0.05 and a log2 fitness score difference > 1.5 as compared to wild-type euploid. To identify gene duplicates more beneficial in ssd1Δ aneuploids than other strains (Fig 5), we required a significantly beneficial effect (log2 fitness score> 0, FDR < 0.05) and a fitness score difference of at least 0.5 in log2 space compared to euploid wild-type, euploid ssd1Δ, and the corresponding wild-type aneuploid, if available. We used a lower magnitude threshold for this analysis since it was required in three separate comparisons. (The Dis4 ssd1Δ strain, which was collected at 5 generations, was compared to 5 generation collections of wild-type euploid, ssd1Δ euploid, and Dis4 wild-type aneuploid, respectively.) This identified 445 gene duplicates that met our criteria in at least one ssd1Δ aneuploid compared to other strains. We relaxed criteria to identify “commonly beneficial” overlapping genes shown in Fig 5B, still requiring a significantly beneficial effect (log2 fitness score > 0, FDR < 0.05) and a higher fitness score relative to comparison strains, but regardless of the magnitude of the difference. To identify genes especially beneficial in wild-type aneuploids, we required a significantly beneficial effect (log2 fitness score> 0, FDR < 0.05) and a fitness score difference of at least 0.5 in log2 space compared to wild-type euploid. We again relaxed this criterion to identify “commonly beneficial” genes, still requiring a significantly beneficial effect (log2 fitness score > 0, FDR < 0.05) and a higher fitness score relative to wild-type euploid, but regardless of the magnitude of the difference.

Supporting information

S1 Fig

Genes scored as neutral in the barcoded library are validated as neutral when strains are grown in isolation.

Two genes that are confidently scored as neutral in the library experiment were selected for investigation. The figure shows the average and standard deviation of relative growth rates of each strain harboring the indicated MoBY 1.0 plasmid vs. empty vector (EV), grown in selective media (SC-His + NTC + G418), n > = 3. The experiment confirms that these plasmids are indeed neutral and validate the library normalization procedure applied in this study.

(TIF)

S2 Fig

Linear modeling using fitness for a small handful of genes.

As shown in Fig 3D but using only the top 10% most toxic genes in ssd1Δ euploid relative to wild-type euploid (x-axis).

(TIF)

S3 Fig

Duplication of select plasmids improves growth of ssd1Δ aneuploids.

A) Average and standard deviation of growth rates for the denoted MoBY 1.0 gene duplication plasmid versus empty vector (EV) in Chr12 aneuploids grown in rich medium (YPD + G418) without NTC (n > = 3, PAB1, SBP1, HYP2/UTR5; n = 2, CDC48, CDC25, GCN20, RPS28B, YPT6, STM1, ARL1, ZDS1, ARF1, ARF2). (*) indicates p < 0.05 of one-tailed, replicate-paired t-test between denoted strain and EV; (+) indicates p < 0.1. B) Average and standard deviation of growth rates for the HYP2/UTR5 plasmid versus empty vector in the indicated strains grown in rich medium YPD + G418 without NTC (n> = 3); (*) indicates p < 0.05 from one-tailed, paired t-test comparing relative growth rates between SSD1+ and ssd1Δ strains; (+) indicates p = 0.08. We were unable to maintain aneuploidy in this experiment in ssd1Δ cells with Chr15 duplication.

(TIF)

S4 Fig

Overlap between genes beneficial to wild-type and ssd1Δ aneuploids.

Venn diagram showing overlap of genes beneficial to two or more ssd1Δ aneuploids (n = 98) and those beneficial to two or more wild-type aneuploids (n = 66). 10 genes (displayed with common names) were identified in both analyses.

(TIF)

S5 Fig

Aneuploid strains are not sensitive to aminoglycosides when they carry the resistance genes.

One concern was that the sensitivity to low doses of NTC in ssd1Δ aneuploids lacking the drug-resistance gene persists in strains carrying drug resistance. We performed several controls to ensure that selection of aneuploidy or the plasmid library using NTC and G418 does not affect aneuploid growth in the library experiments. A) We generated YPS1009_Chr12 and _Chr15 aneuploids in which the two chromosomes were marked with HIS3 and URA3 (dark grey) instead of HIS3 and NATMX (light grey) as used in our study. The growth rate of wild-type and ssd1Δ aneuploids with Chr12 or Chr15 duplication was indistinguishable (p>0.05, independent two-tailed t-test), showing that these strains are not sensitive to NTC when they carry the NATMX cassette (n = 3 except Chr12 ssd1Δ and Chr15 WT SC–His + NTC, where n = 2). B) We also compared growth of all four chromosome duplications, in wild-type and ssd1Δ cells, when cells carried an integrated copy of the KANMX cassette for G418 resistance (n = 3 except Chr12 ssd1Δ and Chr15 ssd1Δ, where n = 2). With the exception of ssd1Δ YPS1009_Chr4 (somewhat confounded by its extreme growth defect), none of the strains grew differently in YPD in the presence or absence of 200 mg/L G418 compared to control. (*) = p < 0.05, independent two-tailed t-test. C) We also compared our library results to a recent study done in the absence of NTC selection but using the same plasmid library [58]. Selection of the library requires G418, which is unavoidable in our study; however, comparing results afforded an opportunity to test the effect of NTC selection used in this study, even though the selection conditions were somewhat different (see [58] for details). Nonetheless, the agreement between the studies were very high considering genes called significant in our analysis (FDR < 0.05): the R2 between log2 fitness scores measured here versus in [58] that used no NTC is 0.78 for the euploid comparison (C) and 0.84 for the YPS1009_Chr12 aneuploid (D). Furthermore, of the 232 genes identified in the present study that are at least 2X more deleterious in YPS1009_Chr12 versus the euploid, 85.5% of them are also more deleterious in the YPS1009_Chr12 versus euploid grown in rich medium without NTC [58]. Among these are many of the genes shown in Fig 4B. Based on these controls, we conclude that the inherent sensitivity to NTC in aneuploid strains that lack the drug-resistance marker does not persist to an appreciable level in the majority of aneuploid strains that carry the drug resistance cassettes. Nonetheless, it remains possible that residual drug sensitivity in ssd1Δ aneuploids could enhance the beneficial effect of some genes identified in this study. We highlight that plasmid validation experiments (S3 Fig) were done in the absence of NTC, confirming that the impact of beneficial genes validated in this study cannot be explained by NTC sensitivity.

(TIF)

S1 Table

Number of replicates and called genes for different experiments.

logFC = log2(fold change) in barcode abundance, taken as fitness score. Cultures were grown for 10 generations unless otherwise noted.

(DOCX)

S2 Table

Strains used in this study.

(DOCX)

S1 Data

Gene duplication fitness scores and associated gene lists.

logFC: measured fitness score (log2(FC = fold change) in barcode abundance) in for the denoted strain. FDR: false discovery rate (B-H correction) corresponding to fitness score for the denoted strain. B1: data generated from Batch 1 growth experiments; B2: data generated from Batch 2 experiments; integrated_analysis: data generated from combined analysis of Batch 1 and Batch 2.

(XLSX)

S2 Data

Data represented in Figs Figs1,1, ,5C,5C, S1, S3A, S3B, S5A and S5B.

(XLSX)

Acknowledgments

Thanks to Michael Place for technical assistance, Norah Paulsen and Emma Mayhew for experimental support, and to the Gasch Lab for helpful comments.

Funding Statement

This work and associated salaries were funded by NIH grants R01CA229532 and R01GM148975 to APG. HAD was supported by training grants T32GM007133 and T32HG002760 to the Genomic Sciences Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Data Availability

Sequencing data and barcode counts are available in the Gene Expression Omnibus (GEO) under accession GSE263221.

References

1. Chunduri NK, Storchová Z. The diverse consequences of aneuploidy. Nat Cell Biol 2019 211. 2019;21: 54–62. 10.1038/s41556-018-0243-8 [Abstract] [CrossRef] [Google Scholar]
2. Pavelka N, Rancati G, Li R. Dr. Jekyll and Mr. Hyde: Role of Aneuploidy in Cellular Adaptation and Cancer. Curr Opin Cell Biol. 2010;22: 809. 10.1016/J.CEB.2010.06.003 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
3. Ricke RM, van Deursen JM. Aneuploidy in health, disease, and aging. J Cell Biol. 2013;201: 11–21. 10.1083/jcb.201301061 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
4. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, et al.. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science (80-). 2007;317: 916–24. 10.1126/science.1142210 [Abstract] [CrossRef] [Google Scholar]
5. Bonney ME, Moriya H, Amon A. Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes. Genes Dev. 2015;29: 898. 10.1101/gad.261743.115 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
6. Birchler JA, Veitia RA. The Gene Balance Hypothesis: implications for gene regulation, quantitative traits and evolution. New Phytol. 2010;186: 54. 10.1111/j.1469-8137.2009.03087.x [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
7. Torres EM, Williams BR, Amon A. Aneuploidy: Cells Losing Their Balance. Genetics. 2008;179: 737–746. 10.1534/genetics.108.090878 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
8. Li R, Zhu J. Effects of aneuploidy on cell behaviour and function. Nat Rev Mol Cell Biol 2022 234. 2022;23: 250–265. 10.1038/s41580-021-00436-9 [Abstract] [CrossRef] [Google Scholar]
9. Lana-Elola E, Watson-Scales SD, Fisher EMC, Tybulewicz VLJ. Down syndrome: searching for the genetic culprits. Dis Model Mech. 2011;4: 586. 10.1242/dmm.008078 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
10. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al.. Down syndrome. Nat Rev Dis Prim. 2020;6: 9. 10.1038/s41572-019-0143-7 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
11. Oromendia AB, Dodgson SE, Amon A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev. 2012;26: 2696–2708. 10.1101/gad.207407.112 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
12. Donnelly N, Storchová Z. Causes and consequences of protein folding stress in aneuploid cells. Cell Cycle. 2015;14: 495–501. 10.1080/15384101.2015.1006043 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
13. Santaguida S, Vasile E, White E, Amon A. Aneuploidy-induced cellular stresses limit autophagic degradation. Genes Dev. 2015;29: 2010–2021. 10.1101/gad.269118.115 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
14. Thorburn RR, Gonzalez C, Brar GA, Christen S, Carlile TM, Ingolia NT, et al.. Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol Biol Cell. 2013;24: 1274–1289. 10.1091/mbc.E12-07-0520 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
15. Sunshine AB, Ong GT, Nickerson DP, Carr D, Murakami CJ, Wasko BM, et al.. Aneuploidy shortens replicative lifespan in Saccharomyces cerevisiae. Aging Cell. 2016;15: 317–324. 10.1111/acel.12443 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
16. Hose J, Yong CM, Sardi M, Wang Z, Newton MA, Gasch AP. Dosage compensation can buffer copynumber variation in wild yeast. Elife. 2015;4. 10.7554/eLife.05462 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
17. Peter J, De Chiara M, Friedrich A, Yue JX, Pflieger D, Bergström A, et al.. Genome evolution across 1,011 Saccharomyces cerevisiae isolates. Nature. 2018;556: 339. 10.1038/s41586-018-0030-5 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
18. Gasch AP, Hose J, Newton MA, Sardi M, Yong M, Wang Z. Further support for aneuploidy tolerance in wild yeast and effects of dosage compensation on gene copy-number evolution. Elife. 2016;5. 10.7554/eLife.14409 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
19. Larrimore KE, Barattin-Voynova NS, Reid DW, Ng DTW. Aneuploidy-induced proteotoxic stress can be effectively tolerated without dosage compensation, genetic mutations, or stress responses. BMC Biol. 2020;18: 117. 10.1186/s12915-020-00852-x [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
20. Scopel EFC, Hose J, Bensasson D, Gasch AP. Genetic variation in aneuploidy prevalence and tolerance across Saccharomyces cerevisiae lineages. Genetics. 2021;217. 10.1093/genetics/iyab015 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
21. Hose J, Escalante LE, Clowers KJ, Dutcher HA, Robinson D, Bouriakov V, et al.. The genetic basis of aneuploidy tolerance in wild yeast. Elife. 2020;9. 10.7554/eLife.52063 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
22. Hogan DJ, Riordan DP, Gerber AP, Herschlag D, Brown PO. Diverse RNA-binding proteins interact with functionally related sets of RNAs, suggesting an extensive regulatory system. Sean R. Eddy, editor. PLoS Biol. 2008;6: 2297–2313. 10.1371/journal.pbio.0060255 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
23. Jansen JM, Wanless AG, Seidel CW, Weiss EL. Cbk1 regulation of the RNA binding protein Ssd1 integrates cell fate with translational control. Curr Biol. 2009;19: 2114. 10.1016/j.cub.2009.10.071 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
24. Bayne RA, Jayachandran U, Kasprowicz A, Bresson S, Tollervey D, Wallace EWJ, et al.. Yeast Ssd1 is a non-enzymatic member of the RNase II family with an alternative RNA recognition site. Nucleic Acids Res. 2022;50: 2923–2937. 10.1093/nar/gkab615 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
25. Ohyama Y, Kasahara K, Kokubo T. Saccharomyces cerevisiae Ssd1p promotes CLN2 expression by binding to the 5′-untranslated region of CLN2 mRNA. Genes to Cells. 2010;15: 1169–1188. 10.1111/j.1365-2443.2010.01452.x [Abstract] [CrossRef] [Google Scholar]
26. Wanless AG, Lin Y, Weiss EL. Cell Morphogenesis Proteins Are Translationally Controlled through UTRs by the Ndr/LATS Target Ssd1. Ohya Y, editor. PLoS One. 2014;9: e85212. 10.1371/journal.pone.0085212 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
27. Kurischko C, Kuravi VK, Herbert CJ, Luca FC. Nucleocytoplasmic shuttling of Ssd1 defines the destiny of its bound mRNAs. Mol Microbiol. 2011;81: 831–849. 10.1111/j.1365-2958.2011.07731.x [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
28. Kurischko C, Broach JR. Phosphorylation and nuclear transit modulate the balance between normal function and terminal aggregation of the yeast RNA-binding protein Ssd1. Strome S, editor. Mol Biol Cell. 2017;28: 3057–3069. 10.1091/mbc.E17-02-0100 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
29. Xu F, Byström AS, Johansson MJO. SSD1 suppresses phenotypes induced by the lack of Elongator-dependent tRNA modifications. Hopper AK, editor. PLoS Genet. 2019;15: e1008117. 10.1371/journal.pgen.1008117 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
30. Hu Z, Xia B, Postnikoff SDDL, Shen ZJ, Tomoiaga AS Harkness TA, et al.. Ssd1 and Gcn2 suppress global translation efficiency in replicatively aged yeast while their activation extends lifespan. Elife. 2018;7: 1–24. 10.7554/eLife.35551 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
31. Khonsari B, Klassen R, Schaffrath R. Role of SSD1 in phenotypic variation of saccharomyces cerevisiae strains lacking DEG1-dependent pseudouridylation. Int J Mol Sci. 2021;22: 8753. 10.3390/ijms22168753 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
32. Rojas J, Hose J, Dutcher HA, Place M, Wolters JF, Hittinger CT, et al.. Comparative modeling reveals the molecular determinants of aneuploidy fitness cost in a wild yeast model. Cell Genomics. 2024;0: 100656. 10.1016/J.XGEN.2024.100656 [Abstract] [CrossRef] [Google Scholar]
33. Tang YC, Amon A. Gene copy number alterations: A cost-benefit analysis. Cell. 2013;152: 394. 10.1016/j.cell.2012.11.043 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
34. Oromendia AB, Amon A. Aneuploidy: implications for protein homeostasis and disease. Dis Model Mech. 2014;7. 10.1242/dmm.013391 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
35. Birchler JA, Veitia RA. Gene balance hypothesis: connecting issues of dosage sensitivity across biological disciplines. Proc Natl Acad Sci U S A. 2012;109: 14746–14753. 10.1073/pnas.1207726109 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
36. Veitia RA. Exploring the etiology of haploinsufficiency. BioEssays. 2002;24: 175–184. 10.1002/bies.10023 [Abstract] [CrossRef] [Google Scholar]
37. Brennan CM, Vaites LP, Wells JN, Santaguida S, Paulo JA, Storchova Z, et al.. Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells. Genes Dev. 2019;33: 1031–1047. 10.1101/gad.327494.119 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
38. Tsai HJ, Nelliat AR, Choudhury MI, Kucharavy A, Bradford WD, Cook ME, et al.. Hypo-osmotic-like stress underlies general cellular defects of aneuploidy. Nature. 2019;570: 117–121. 10.1038/s41586-019-1187-2 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
39. Anders KR, Kudrna JR, Keller KE, Kinghorn BAA, Miller EM, Pauw D, et al.. A strategy for constructing aneuploid yeast strains by transient nondisjunction of a target chromosome. BMC Genet. 2009;10: 1–11. 10.1186/1471-2156-10-36/TABLES/3 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
40. Ho CH, Magtanong L, Barker SL, Gresham D, Nishimura S, Natarajan P, et al.. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol. 2009;27: 369–377. 10.1038/nbt.1534 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
41. Vavouri T, Semple JI, Garcia-Verdugo R, Lehner B. Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell. 2009;138: 198–208. 10.1016/j.cell.2009.04.029 [Abstract] [CrossRef] [Google Scholar]
42. Mann C, Davis RW. Instability of dicentric plasmids in yeast. Proc Natl Acad Sci U S A. 1983;80: 228. 10.1073/pnas.80.1.228 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
43. Hill A, Bloom K. Genetic manipulation of centromere function. Mol Cell Biol. 1987;7: 2397. 10.1128/mcb.7.7.2397-2405.1987 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
44. Storchová Z, Breneman A, Cande J, Dunn J, Burbank K, O’Toole E, et al.. Genome-wide genetic analysis of polyploidy in yeast. Nat 2006 4437111. 2006;443: 541–547. 10.1038/nature05178 [Abstract] [CrossRef] [Google Scholar]
45. Dodgson SE, Santaguida S, Kim S, Sheltzer J, Amon A. The pleiotropic deubiquitinase Ubp3 confers aneuploidy tolerance. Genes Dev. 2016;30: 2259–2271. 10.1101/gad.287474.116 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
46. Rojas M, Gingras AC, Dever TE. Protein phosphatase PP1/GLC7 interaction domain in yeast eIF2γ bypasses targeting subunit requirement for eIF2α dephosphorylation. Proc Natl Acad Sci U S A. 2014;111: E1344. 10.1073/PNAS.1400129111 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
47. Palanimurugan R, Scheel H, Hofmann K, Dohmen RJ. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme. EMBO J. 2004;23: 4857. 10.1038/sj.emboj.7600473 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
48. Schnier J, Schwelberger HG, Smit-Mcbride Z, Kang HA, Hershey JWB. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1991;11: 3105. 10.1128/mcb.11.6.3105-3114.1991 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
49. Park MH, Wolff EC. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation. J Biol Chem. 2018;293: 18710–18718. 10.1074/jbc.TM118.003341 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
50. Guydosh NR, Green R. Dom34 Rescues Ribosomes in 3´ Untranslated Regions. Cell. 2014;156: 950. 10.1016/j.cell.2014.02.006 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
51. Halwas K, Döring LM, Oehlert FV, Dohmen RJ. Hypusinated eIF5A Promotes Ribosomal Frameshifting during Decoding of ODC Antizyme mRNA in Saccharomyces cerevisiae. Int J Mol Sci. 2022;23. Available: https://pubmed.ncbi.nlm.nih.gov/36361762/. [Europe PMC free article] [Abstract] [Google Scholar]
52. Uemura T, Kashiwagi K, Igarashi K. Polyamine Uptake by DUR3 and SAM3 in Saccharomyces cerevisiae. J Biol Chem. 2007;282: 7733–7741. 10.1074/jbc.M611105200 [Abstract] [CrossRef] [Google Scholar]
53. Polevoda B, Span L, Sherman F. The yeast translation release factors Mrf1p and Sup45p (eRF1) are methylated, respectively, by the methyltransferases Mtq1p and Mtq2p. J Biol Chem. 2006;281: 2562–2571. 10.1074/jbc.M507651200 [Abstract] [CrossRef] [Google Scholar]
54. Cuchalová L, Kouba T, Herrmannová A, Dányi I, Chiu W, Valášek L. The RNA Recognition Motif of Eukaryotic Translation Initiation Factor 3g (eIF3g) Is Required for Resumption of Scanning of Posttermination Ribosomes for Reinitiation on GCN4 and Together with eIF3i Stimulates Linear Scanning. Mol Cell Biol. 2010;30: 4671. 10.1128/MCB.00430-10 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
55. Beznosková P, Wagner S, Jansen ME, Von Der Haar T, Valášek LS. Translation initiation factor eIF3 promotes programmed stop codon readthrough. Nucleic Acids Res. 2015;43: 5099. 10.1093/nar/gkv421 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
56. Ling J, Cho C, Guo LT, Aerni HR, Rinehart J, Söll D. Protein Aggregation Caused by Aminoglycoside Action Is Prevented by a Hydrogen Peroxide Scavenger. Mol Cell. 2012;48: 713–722. 10.1016/j.molcel.2012.10.001 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
57. Haupt I, Hübener R, Thrum H. Streptothricin F, an inhibitor of protein synthesis with miscoding activity. J Antibiot (Tokyo). 1978;31: 1137–1142. 10.7164/antibiotics.31.1137 [Abstract] [CrossRef] [Google Scholar]
58. Escalante LE, Hose J, Howe H, Paulsen N, Place M, Gasch AP. Premature aging in aneuploid yeast is caused in part by aneuploidy-induced defects in Ribosome Quality Control. bioRxiv. 2024. 10.1101/2024.06.22.600216 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
59. Dodgson SE, Kim S, Costanzo M, Baryshnikova A, Morse DL, Kaiser CA, et al.. Chromosome-specific and global effects of aneuploidy in Saccharomyces cerevisiae. Genetics. 2016;202: 1395–1409. 10.1534/genetics.115.185660 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
60. Dürrbaum M, Kruse C, Nieken KJ, Habermann B, Storchová Z. The deregulated microRNAome contributes to the cellular response to aneuploidy. BMC Genomics. 2018;19: 1–17. 10.1186/S12864-018-4556-6/TABLES/4 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
61. Dürrbaum M, Kuznetsova AY, Passerini V, Stingele S, Stoehr G, Storchová Z. Unique features of the transcriptional response to model aneuploidy in human cells. BMC Genomics. 2014;15: 139. 10.1186/1471-2164-15-139 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
62. Adorno M, Sikandar S, Mitra SS, Kuo A, Di Robilant BN, Haro-Acosta V, et al.. Usp16 contributes to somatic stem-cell defects in Down’s syndrome. Nat 2013 5017467. 2013;501: 380–384. 10.1038/nature12530 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
63. Liu H, Huang S, Wang W, Wang H, Huang W, Zhai Z, et al.. Migration deficits of the neural crest caused by CXADR triplication in a human Down syndrome stem cell model. Cell Death Dis. 2022;13. 10.1038/S41419-022-05481-6 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
64. Cai F, Song B, Yang Y, Liao H, Li R, Wang Z, et al.. USP25 contributes to defective neurogenesis and cognitive impairments. FASEB J. 2023;37: e22971. 10.1096/fj.202300057R [Abstract] [CrossRef] [Google Scholar]
65. Atas-Ozcan H, Brault V, Duchon A, Herault Y. Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes (Basel). 2021;12. 10.3390/GENES12111833 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
66. Salehi A, Delcroix JD, Belichenko P V., Zhan K, Wu C, Valletta JS, et al.. Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006;51: 29–42. 10.1016/j.neuron.2006.05.022 [Abstract] [CrossRef] [Google Scholar]
67. Rogers DW, Böttcher MA, Traulsen A, Greig D. Ribosome reinitiation can explain length-dependent translation of messenger RNA. PLOS Comput Biol. 2017;13: e1005592. 10.1371/journal.pcbi.1005592 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
68. Thompson MK, Gilbert W V. mRNA length-sensing in eukaryotic translation: reconsidering the “closed loop” and its implications for translational control. Curr Genet. 2017;63: 613. 10.1007/s00294-016-0674-3 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
69. Ascencio D, Diss G, Gagnon-Arsenault I, Dubé AK, DeLuna A, Landry CR. Expression attenuation as a mechanism of robustness against gene duplication. Proc Natl Acad Sci U S A. 2021;118: e2014345118. 10.1073/pnas.2014345118 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
70. Dephoure N, Hwang S, O’Sullivan C, Dodgson SE, Gygi SP, Amon A, et al.. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. Elife. 2014;3: 1–27. 10.7554/eLife.03023 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
71. Schukken KM, Sheltzer JM. Extensive protein dosage compensation in aneuploid human cancers. Genome Res. 2022;32: 1254–1270. 10.1101/gr.276378.121 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
72. Zhang C, Wang X, Park S, Chiang YC, Xi W, Laue TM, et al.. Only a subset of the PAB1-mRNP proteome is present in mRNA translation complexes. Protein Sci. 2014;23: 1036. 10.1002/pro.2490 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
73. Rössler I, Embacher J, Pillet B, Murat G, Liesinger L, Hafner J, et al.. Tsr4 and Nap1, two novel members of the ribosomal protein chaperOME. Nucleic Acids Res. 2019;47: 6984. 10.1093/nar/gkz317 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
74. Aviner R, Lee TT, Masto VB, Li KH, Andino R, Frydman J. Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington’s disease. Nat Cell Biol 2024 266. 2024;26: 892–902. 10.1038/s41556-024-01414-x [Abstract] [CrossRef] [Google Scholar]
75. Spealman P, de Santana C, De T, Gresham D. Post-transcriptional mechanisms modulate the consequences of adaptive copy number variation. bioRxiv. 2023; 2023.10.20.563336. 10.1101/2023.10.20.563336 [CrossRef] [Google Scholar]
76. Baker NE, Montagna C. Reducing the aneuploid cell burden–cell competition and the ribosome connection. Dis Model Mech. 2022;15. 10.1242/dmm.049673 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
77. Chunduri NK, Menges P, Zhang X, Wieland A, Gotsmann VL, Mardin BR, et al.. Systems approaches identify the consequences of monosomy in somatic human cells. Nat Commun. 2021;12. 10.1038/S41467-021-25288-X [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
78. Dutcher HA, Gasch AP. Investigating the role of RNA-binding protein Ssd1 in aneuploidy tolerance through network analysis. bioRxiv. 2024; 2024.07.19.604323. 10.1101/2024.07.19.604323 [Abstract] [CrossRef] [Google Scholar]
79. Zinshteyn B, Gilbert W V. Loss of a Conserved tRNA Anticodon Modification Perturbs Cellular Signaling. PLoS Genet. 2013;9: 1003675. 10.1371/journal.pgen.1003675 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
80. Nedialkova DD, Leidel SA. Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity. Cell. 2015;161: 1606–1618. 10.1016/j.cell.2015.05.022 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
81. Chou HJ, Donnard E, Gustafsson HT, Garber M, Rando OJ. Transcriptome-wide Analysis of Roles for tRNA Modifications in Translational Regulation. Mol Cell. 2017;68: 978–992.e4. 10.1016/j.molcel.2017.11.002 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
82. Patil A, Chan CTY, Dyavaiah M, Rooney JP, Dedon PC, Begley TJ. Translational infidelity-induced protein stress results from a deficiency in Trm9-catalyzed tRNA modifications. RNA Biol. 2012;9: 990–1001. 10.4161/rna.20531 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
83. Robinson DE, Place M, Hose J, Jochem A, Gasch AP. Natural variation in the consequences of gene overexpression and its implications for evolutionary trajectories. Elife. 2021;10. 10.7554/eLife.70564 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
84. Piotrowski JS, Simpkins SW, Li SC, Deshpande R, McIlwain SJ, Ong IM, et al.. Chemical genomic profiling via barcode sequencing to predict compound mode of action. Methods Mol Biol. 2015;1263: 299. 10.1007/978-1-4939-2269-7_23 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
85. Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11: 1–9. 10.1186/gb-2010-11-3-r25 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
86. Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26: 139–140. 10.1093/bioinformatics/btp616 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
87. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B. 1995;57: 289–300. 10.1111/J.2517-6161.1995.TB02031.X [CrossRef] [Google Scholar]
88. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95: 14863. 10.1073/pnas.95.25.14863 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
89. Saldanha AJ. Java Treeview—extensible visualization of microarray data. Bioinformatics. 2004;20: 3246–3248. 10.1093/bioinformatics/bth349 [Abstract] [CrossRef] [Google Scholar]
90. Simillion C, Liechti R, Lischer HEL, Ioannidis V, Bruggmann R. Avoiding the pitfalls of gene set enrichment analysis with SetRank. BMC Bioinformatics. 2017;18: 151. 10.1186/s12859-017-1571-6 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
91. Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, Chan ET, et al.. Saccharomyces Genome Database: The genomics resource of budding yeast. Nucleic Acids Res. 2012;40. 10.1093/nar/gkr1029 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
92. Bailey TL. Discovering Novel Sequence Motifs with MEME. Curr Protoc Bioinforma. 2003;00: 2.4.1–2.4.35. 10.1002/0471250953.BI0204S00 [Abstract] [CrossRef] [Google Scholar]
93. Bailey TL, Grant CE. SEA: Simple Enrichment Analysis of motifs. bioRxiv. 2021; 2021.08.23.457422. 10.1101/2021.08.23.457422 [CrossRef] [Google Scholar]
94. Erdos G, Pajkos M, Dosztányi Z. IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation. Nucleic Acids Res. 2021;49: W297. 10.1093/nar/gkab408 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
95. Balakrishnan R, Park J, Karra K, Hitz BC, Binkley G, Hong EL, et al.. YeastMine—an integrated data warehouse for Saccharomyces cerevisiae data as a multipurpose tool-kit. Database J Biol Databases Curation. 2012;2012. 10.1093/database/bar062 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
96. Stein KC, Morales-Polanco F, van der Lienden J, Rainbolt TK, Frydman J. Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis. Nature. 2022;601: 637. 10.1038/s41586-021-04295-4 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]

Articles from PLOS Genetics are provided here courtesy of PLOS

Citations & impact 


This article has not been cited yet.

Impact metrics

Alternative metrics

Altmetric item for https://www.altmetric.com/details/169726170
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/169726170

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 


Funders who supported this work.

NCI NIH HHS (1)

NHGRI NIH HHS (1)

NIGMS NIH HHS (2)

National Cancer Institute (1)

National Human Genome Research Institute (1)

National Institute of General Medical Sciences (2)